We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The equipment “will allow patients to be safely transitioned into the MRI suite without the interruption of infusion therapy,” the company said. Read More
J&J previously announced that it expects to begin a phase 3 trial of its vaccine candidate, Ad26.COV2.S, in 60,000 participants in early September. Read More
The test provides comprehensive genomic profiling results, reporting on genomic alterations that include genomic signatures and single-gene alterations. Read More
The graft is available in two delivery formats, a standard syringe and a minimally invasive cartridge used with the company’s GraftGun system. Read More
VBI received a $42 million contract from the Canadian government earlier this month to support its COVID-19 vaccine development program through phase 2 testing. Read More
When determining whether to issue an EUA for a multi-analyte respiratory panel that includes SARS-CoV-2, the agency said it considers the clearance or approval status of diagnostics for the other analytes on the panel. Read More